Cue Biopharma Enters Material Definitive Agreement
Ticker: CUE · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1645460
| Field | Detail |
|---|---|
| Company | Cue Biopharma, Inc. (CUE) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action
TL;DR
Cue Biopharma just signed a big deal, filing an 8-K on 6/30/25.
AI Summary
On June 30, 2025, Cue Biopharma, Inc. entered into a material definitive agreement. The company, formerly known as Imagen Biopharma, Inc., is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
This filing indicates a significant new contract or partnership for Cue Biopharma, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering a material definitive agreement is a significant event that could carry substantial risks and rewards, warranting a medium risk assessment.
Key Numbers
- 001-38327 — SEC File Number (Identifies the specific filing with the SEC)
- 47-3324577 — IRS Employer Identification No. (Tax identification for the company)
Key Players & Entities
- Cue Biopharma, Inc. (company) — Registrant
- Imagen Biopharma, Inc. (company) — Former company name
- June 30, 2025 (date) — Date of earliest event reported
- 40 Guest Street Boston, Massachusetts 02135 (address) — Principal executive offices
- 001-38327 (filing_id) — SEC File Number
FAQ
What is the nature of the material definitive agreement entered into by Cue Biopharma, Inc. on June 30, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into on June 30, 2025.
What was Cue Biopharma, Inc.'s former company name?
Cue Biopharma, Inc.'s former company name was Imagen Biopharma, Inc.
Where are Cue Biopharma, Inc.'s principal executive offices located?
Cue Biopharma, Inc.'s principal executive offices are located at 40 Guest Street, Boston, Massachusetts 02135.
What is the SEC file number for this Form 8-K filing?
The SEC file number for this Form 8-K filing is 001-38327.
What is the IRS Employer Identification Number for Cue Biopharma, Inc.?
The IRS Employer Identification Number for Cue Biopharma, Inc. is 47-3324577.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Cue Biopharma, Inc. (CUE).